Zobrazeno 1 - 10
of 42
pro vyhledávání: '"F. Boulerice"'
Autor:
F. Boulerice, Jean-Guy Baril, Richard G. Lalonde, Mona Loutfy, Cécile Tremblay, John S. Sampalis, Anita Rachlis, Benoit Trottier
Publikováno v:
HIV clinical trials. 12(3)
To describe the durability of treatment, virological and immunological response, and safety of an atazanavir/ritonavir (ATV/RTV)-based highly active antiretroviral therapy (HAART) regimen in treatment-naïve HIV-infected patients.This was a multicent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642d9f89d3f4eb5307551688c2967261
https://pubmed.ncbi.nlm.nih.gov/21684855
https://pubmed.ncbi.nlm.nih.gov/21684855
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:1305-1312
We investigated whether cells derived from the fetal central nervous system can support productive infection by a human immunodeficiency virus type 1 (HIV-1) isolate termed UHC-1, produced by a cellular clone derived from HIV-1 strain HIV-IIIB chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ad40c859cc13a1d9b6fe9053298792
https://doi.org/10.1128/aac.37.6.1305
https://doi.org/10.1128/aac.37.6.1305
Publikováno v:
Biochemical and Biophysical Research Communications. 174:1272-1280
During retroviral assembly, tRNAs are incorporated into the virion, one of which serves as a primer for the reverse transcription reaction. Using two dimensional polyacrylamide gel electrophoresis, we have studied the patterns of tRNAs incorporated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ab6ebeea22ab2ec86bc1271201b572
https://doi.org/10.1016/0006-291x(91)91559-u
https://doi.org/10.1016/0006-291x(91)91559-u
Autor:
H.S. Conter, D. Roy, Edwin R. Brankston, C. Laroche, Michèle Rivard, P. Forget, R. Kelly, R. Roy, C. Savard, R. Corriveau, J.M. Martel, F. Boulerice
Publikováno v:
Clinical drug investigation. 15(2)
The objective of this multicentre, randomised, open-label, general practice (GP) study was to evaluate the efficacy and tolerability of cefprozil (Cefzil(trade mark), Bristol-Myers Squibb) compared with that of cefuroxime axetil (Ceftin((R)), Glaxo W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0924916a7056cbd2f5181feeff1c09df
https://pubmed.ncbi.nlm.nih.gov/18370472
https://pubmed.ncbi.nlm.nih.gov/18370472
Publikováno v:
Journal of Virology. 64:1745-1755
Limiting-dilution techniques were employed to derive single-cell clones from U-937 cells that had been chronically infected with human immunodeficiency virus type 1. All clones thus obtained were positive for the presence of viral antigens; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f79097b580b22cf75d002b7c2cfc57
https://doi.org/10.1128/jvi.64.4.1745-1755.1990
https://doi.org/10.1128/jvi.64.4.1745-1755.1990
Autor:
G. Murray, C. Rotstein, D. A. Campbell, J. Laforge, R. A. McIvor, S. J. Landis, F. Boulerice, H. G. Stiver, R. Saginur, R. Grossman, M. Rivard, J. Dubois, G. E. Garber
Publikováno v:
The Journal of antimicrobial chemotherapy. 43(4)
In a prospective, multicentre double-blind trial, 151 patients over the age of 65 years were randomly assigned to receive either cefepime 2 g every 12 h for a minimum of 3 days and up to 14 days or ceftriaxone 1 g every 12 h for a minimum of 3 days a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804c915fe73d06f1d96a0ec18a13ec19
https://pubmed.ncbi.nlm.nih.gov/10350385
https://pubmed.ncbi.nlm.nih.gov/10350385
Autor:
J S, Montaner, A, Rachlis, R, Beaulieu, J, Gill, W, Schlech, P, Phillips, C, Auclair, F, Boulerice, A, Schindzielorz, L, Smaldone
Publikováno v:
Journal of acquired immune deficiency syndromes. 7(9)
The aim of this study was to ascertain the safety profile of didanosine (Videx; ddI) within the Canadian Open Treatment Program. Symptomatic HIV+ subjects with AIDS or ARC or CD4200/mm3 were eligible to receive didanosine if they were either (a) into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53cf19f70383e89a54b2615f1743292e
https://pubmed.ncbi.nlm.nih.gov/7519674
https://pubmed.ncbi.nlm.nih.gov/7519674
Publikováno v:
The Journal of Experimental Medicine
The effects of human immunodeficiency virus 1 (HIV-1) infection on cellular differentiation and NF-kappa B DNA binding activity have been investigated in a new model of myeloid differentiation. PLB-985 cells represent a bipotential myelomonoblastic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ea38f41b29fdfca93c0563bc5322e2
https://pubmed.ncbi.nlm.nih.gov/1740663
https://pubmed.ncbi.nlm.nih.gov/1740663
Autor:
M D'Addario, H L Li, F Boulerice, Stephan Bour, R Geleziunas, Mark A. Wainberg, John Hiscott, Anne Roulston
Single-cell clones derived from the U-937 monocytic cell line were studied for susceptibility to infection by human immunodeficiency virus type 1 (HIV-1). Of four such clones, we found that three (UC12, UC14, and UC18) supported replication of HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427132722b356b3037c1095306c25059
https://europepmc.org/articles/PMC240823/
https://europepmc.org/articles/PMC240823/
Our results demonstrate that the formation of intracellular complexes between the envelope glycoprotein precursor gp160 of human immunodeficiency virus type 1 and CD4 is a major event, leading to the disappearance of CD4 at the cell surface of infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d90f29bbe1931a8b708ff7f9667dfba9
https://europepmc.org/articles/PMC250675/
https://europepmc.org/articles/PMC250675/